Skip to content

Convergence of Cannabis and Psychosis on the Dopamine System

Jessica Ahrens, Sabrina D. Ford, Betsy Schaefer, David Reese, Ali R. Khan, Philip G. Tibbo, Rachel A Rabin, Clifford M. Cassidy, Lena Palaniyappan

JAMA Psychiatry April 9, 2025 DOI: 10.1001/jamapsychiatry.2025.0432 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational cohort Peer reviewed
Topics Cannabis
Key findings Cannabis use is associated with alterations in the midbrain dopamine pathway involved in psychosis.

Abstract

This cohort study investigates the association between cannabis and the midbrain dopamine pathway involved in psychosis.

Comparable studies

Other observational and cohort studies on cannabis, most cited first.

Study Year Design Participants
High-potency cannabis and the risk of psychosis People with first episode of psychosis and healthy controls from the local population 2009 Case-control study n = 454
Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada Rural aboriginal population 2013 Observational study
Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) Otherwise healthy young people 2000 Observational
Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study Individuals from the general population in Germany aged 14-24 at baseline 2011 Observational cohort n = 1,923
Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases Patients treated for cannabis-induced psychotic symptoms in Denmark between 1994 and... 2005 Observational cohort n = 535

Citations in the library

Explore topics